American Pharmaceutical Review: Controlled Release Roundtable

Recro’s Bhavik Bhatt, Ph.D., participated in the Controlled Release Roundtable published by APR in June 2020. He and 11 other scientists answered questions on recent developments in controlled release (CR) technologies, how bioavailability and solubility influence development, and what indications benefit most from CR applications.

Want to know more?

Read the article

Back to Thought Leadership